This is particularly relevant on GLP-1 medications, where the primary issue is slowed gastric emptying
Fatigue is actually listed as a common adverse reaction in the Summary of Product Characteristics (SmPC) for some GLP-1 receptor agonists, particularly those used at higher doses for weight management such as semaglutide 2.4mg (Wegovy) and liraglutide 3mg (Saxenda)
Different Formulations Matter: While injectable semaglutide (Ozempic, Wegovy) shows minimal transfer into breast milk, the oral form (Rybelsus) contains an absorption enhancer that could potentially accumulate in infants and is strictly not recommended during lactation
In: Ferroptosis: Mechanism and diseases
This is your body telling you that it does not have enough energy to support reproductive function
GLP-1 shots versus pills, convenience or more weight loss Injectable GLP-1s have shown slightly higher effectiveness for weight loss in clinical trials compared to oral versions